Description

Organ-specific metabolite concentration changes following dexamethasone exposure, quantified by chemical isotope labeling LC-MS. The tissue-level analysis captures the heterogeneous metabolic response to glucocorticoid treatment.

Figure 18

Chart

Source Paper

Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS analysis.

Metabolites (2020)

PMID: 31973046

DOI: 10.3390/metabo10020042

Cite This Figure

![Figure 18: Organ-specific metabolite concentration changes following dexamethasone exposure, quantified by chemical isotope labeling LC-MS. The tissue-level analysis captures the heterogeneous metabolic response to glucocorticoid treatment.]()

> Source: Lina A Dahabiyeh et al. "Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical ." *Metabolites*, 2020. PMID: [31973046](https://pubmed.ncbi.nlm.nih.gov/31973046/)

<figure>
  <img src="" alt="Organ-specific metabolite concentration changes following dexamethasone exposure, quantified by chemical isotope labeling LC-MS. The tissue-level analysis captures the heterogeneous metabolic response to glucocorticoid treatment." />
  <figcaption>Figure 18. Organ-specific metabolite concentration changes following dexamethasone exposure, quantified by chemical isotope labeling LC-MS. The tissue-level analysis captures the heterogeneous metabolic response to glucocorticoid treatment.<br>  Source: Lina A Dahabiyeh et al. "Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical ." <em>Metabolites</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31973046/">31973046</a></figcaption>
</figure>

Preuves associées

Uridine Monophosphate pour Neurotransmitter Imbalance

Note C · 4 études